Suchitrita S相关文献与解析，生知库 | 链接生命科学的每一步

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)

伊克珠单抗治疗未接受过生物制剂治疗的活动性银屑病关节炎患者：一项 III 期临床试验 (SPIRIT-P1) 的 3 年结果

Chandran, Vinod; van der Heijde, Désirée; Fleischmann, Roy M; Lespessailles, Eric; Helliwell, Philip S; Kameda, Hideto; Burgos-Vargas, Ruben; Erickson, Janelle S; Rathmann, Suchitrita S; Sprabery, Aubrey Trevelin; Birt, Julie A; Shuler, Catherine L; Gallo, Gaia

银屑病

关节炎

发表日期：2020

文献求助收藏

Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks

评估拉米地坦给药后2小时对难治性偏头痛急性发作的疗效

期刊:Headache

影响因子:4

doi:10.1111/head.13897

Tepper, Stewart J; Vasudeva, Raghavendra; Krege, John H; Rathmann, Suchitrita S; Doty, Erin; Vargas, Bert B; Magis, Delphine; Komori, Mika

Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors

对于患有活动性银屑病关节炎且先前对肿瘤坏死因子抑制剂反应不足或不耐受的患者，伊克珠单抗单独使用或与传统合成疾病修饰抗风湿药物（cDMARDs）联合使用均有效。

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2018-000692

Nash, Peter; Behrens, Frank; Orbai, Ana-Maria; Rathmann, Suchitrita S; Adams, David H; Benichou, Olivier; Deodhar, Atul

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

甲氨蝶呤剂量递增联合阿达木单抗的疗效和安全性：随机 CONCERTO 试验

期刊:Annals of the Rheumatic Diseases

影响因子:20.6

doi:10.1136/annrheumdis-2013-204769

Burmester, Gerd-Rűdiger; Kivitz, Alan J; Kupper, Hartmut; Arulmani, Udayasankar; Florentinus, Stefan; Goss, Sandra L; Rathmann, Suchitrita S; Fleischmann, Roy M

发表日期：2015

文献求助收藏

Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis

在活动性非放射性中轴型脊柱关节炎患者中，磁共振成像显示骶髂关节炎症缺失，但脊柱存在炎症

期刊:Arthritis & Rheumatology

影响因子:10.9

doi:10.1002/art.38283

van der Heijde, Désirée; Sieper, Joachim; Maksymowych, Walter P; Brown, Matthew A; Lambert, Robert G W; Rathmann, Suchitrita S; Pangan, Aileen L

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

拉米地坦治疗后功能改善：3期研究数据的后验分析

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)

伊克珠单抗治疗未接受过生物制剂治疗的活动性银屑病关节炎患者：一项 III 期临床试验 (SPIRIT-P1) 的 3 年结果

Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks

评估拉米地坦给药后2小时对难治性偏头痛急性发作的疗效

Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors

对于患有活动性银屑病关节炎且先前对肿瘤坏死因子抑制剂反应不足或不耐受的患者，伊克珠单抗单独使用或与传统合成疾病修饰抗风湿药物（cDMARDs）联合使用均有效。

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

甲氨蝶呤剂量递增联合阿达木单抗的疗效和安全性：随机 CONCERTO 试验

Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis

在活动性非放射性中轴型脊柱关节炎患者中，磁共振成像显示骶髂关节炎症缺失，但脊柱存在炎症